Size | Price | Stock | Qty |
---|---|---|---|
5mg |
|
||
10mg |
|
||
25mg |
|
||
50mg |
|
||
100mg |
|
||
500mg |
|
||
Other Sizes |
|
Purity: ≥98%
8-Nitrotryptanthrin is a potent selective inhibitor of the human indoleamine 2,3-dioxygenase 2 (hIDO2) which dramatically reduces IDO2 activity with Ki value of 0.97 μM. As an analogue of IDO1 (indoleamine 2, 3-dioxygenase 1), the well-known new therapeutic target, IDO2 is receiving increased attention for its potential therapeutic applications. The typtanthrin derivative 8-Nitrotryptanthrin is found to be a potent hIDO2 inhibitor with superior efficiency much better than that of the most frequently-used inhibitor L-1-MT. 8-Nitrotryptanthrin has a microplate Alamar Blue assay (MABA) minimum inhibitory concentration (MIC) value of 0.032 μg/mL. 8-Nitrotryptanthrin also has a LORA MIC value of 2.4 μg/mL, while the majority of analogues lack LORA activity.
ln Vitro |
It has been discovered that the tytanthrin derivative GNF-PF-3777 (8-Nitrotryptanthrin; compound 5i) is a strong hIDO2 inhibitor with exceptional efficiency, far more effective than the most widely used inhibitor L-1-MT. All nine tryptophan compounds exhibited hIDO2 inhibitory activity, as indicated by IC50 values. GNF-PF-3777 demonstrated a stronger inhibitory effect than D-1-MT (262.75 μM) and L-1-MT (82.53 μM) (1.87 μM). GNF-PF-3777 has an EC50 of 0.82 μM and demonstrates strong anti-trypanosome activity[2]. The minimum inhibitory concentration (MIC) of GNF-PF-3777 (8-nitrotryptamine) in the microplate Alamar Blue assay (MABA) is 0.032 μg/mL. GNF-PF-3777 has a LORA MIC of 2.4 μg/mL, whereas the majority of its analogues don't exhibit any LORA activity [3].
|
||
---|---|---|---|
ln Vivo |
|
||
Animal Protocol |
|
||
References |
|
Molecular Formula |
C15H7N3O4
|
|
---|---|---|
Molecular Weight |
293.234
|
|
Exact Mass |
293.04
|
|
Elemental Analysis |
C, 61.44; H, 2.41; N, 14.33; O, 21.82
|
|
CAS # |
77603-42-0
|
|
Related CAS # |
|
|
PubChem CID |
478573
|
|
Appearance |
White to off-white solid powder
|
|
LogP |
1.9
|
|
Hydrogen Bond Donor Count |
0
|
|
Hydrogen Bond Acceptor Count |
5
|
|
Rotatable Bond Count |
0
|
|
Heavy Atom Count |
22
|
|
Complexity |
582
|
|
Defined Atom Stereocenter Count |
0
|
|
InChi Key |
UFMQJYHLIUACCG-UHFFFAOYSA-N
|
|
InChi Code |
InChI=1S/C15H7N3O4/c19-13-10-7-8(18(21)22)5-6-12(10)17-14(13)16-11-4-2-1-3-9(11)15(17)20/h1-7H
|
|
Chemical Name |
8-nitroindolo[2,1-b]quinazoline-6,12-dione
|
|
Synonyms |
|
|
HS Tariff Code |
2934.99.9001
|
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
|
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
|
|||
---|---|---|---|---|
Solubility (In Vivo) |
|
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 3.4103 mL | 17.0515 mL | 34.1029 mL | |
5 mM | 0.6821 mL | 3.4103 mL | 6.8206 mL | |
10 mM | 0.3410 mL | 1.7051 mL | 3.4103 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Eur J Med Chem.2016 Nov 10;123:171-179. th> |
---|